sharetrader
Results 1 to 4 of 4
  1. #1
    Junior Member
    Join Date
    Mar 2021
    Location
    wellington
    Posts
    14

    Default VHT - Volpara Health, NZ company listed on the ASX

    Hi,

    I recently had a look at VHT, kiwi health software company, after personal life event.

    They released their results for the FY. I bought a bit for a long term run.

    What do you guys think about it?

    - SaaS company producing different software and an AI algorithm to calculate breast density and risks
    - they bought CRA in January, a company that is more into genetic, still in the breast industry
    - they hired people from GE With extensive experience to lead their sales

    Cheers

  2. #2
    Junior Member
    Join Date
    Mar 2021
    Location
    wellington
    Posts
    14

    Default

    CEO Ralph Highnam will be interviewed during Sharesies event "Lunch money". I will follow it, but the video will be uploaded on Youtube after.

    And VHT released a video for investor about their Q4 result on their website, really interesting as well.

  3. #3
    Junior Member
    Join Date
    Mar 2021
    Location
    wellington
    Posts
    14

    Default

    Quick update from their financial report for FY 2020-2021. Their results look good. still loosing money but they are improving. Hopefully in 1-2 years, they will start making profits!

    Highlights:
    • Record revenue from customer contracts up 57% to NZ$19.7M
    • Subscription revenue up 99% to NZ$18.1M
    • Gross margin up to over 91%, from 86% in FY20
    • Net loss for the year after tax improved 14% to NZ$17.5M
    • Normalised non-GAAP EBITDA1 improved 21% to -NZ$12.4M
    • Volpara expects revenue in FY22 of approx. NZ$25.0M to NZ$26.0M

  4. #4
    Junior Member
    Join Date
    Mar 2021
    Location
    wellington
    Posts
    14

    Default

    Quick update from their financial report for FY 2020-2021. Their results look good. still loosing money but they are improving. Hopefully in 1-2 years, they will start making profits!

    Highlights:
    • Record revenue from customer contracts up 57% to NZ$19.7M
    • Subscription revenue up 99% to NZ$18.1M
    • Gross margin up to over 91%, from 86% in FY20
    • Net loss for the year after tax improved 14% to NZ$17.5M
    • Normalised non-GAAP EBITDA1 improved 21% to -NZ$12.4M
    • Volpara expects revenue in FY22 of approx. NZ$25.0M to NZ$26.0M

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •